Tvardi Therapeutics (TVRD) Net Equity Issued and Repurchased (2014 - 2025)
Tvardi Therapeutics' Net Equity Issued and Repurchased came in at $1,000 for Q4 2025, down 99.1% from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) Net Equity Issued and Repurchased (2014 - 2025) Analysis & Trends
For FY2025, Tvardi Therapeutics' Net Equity Issued and Repurchased was $532,000.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -5.1% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $5,000 in FY2024 (-99.6%), $1.12 million in FY2023 (+259.2%), $311,000 in FY2022 (-81.0%) and $1.64 million in FY2021 (+137.2%).
- The Q4 2025 figure represents the lowest quarterly Net Equity Issued and Repurchased since Q4 2019.
- The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q1 2021 (growth of 817.3%), and the weakest in Q1 2022 (a decline of 99.6%).
- Business Quant data shows TVRD's Net Equity Issued and Repurchased at $107,000 (Q3 2025), $421,000 (Q2 2025) and $3,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Tvardi Therapeutics | 11.73 Mn | 11.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | 421,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Sep 30, 2023 | 557,000.00 |
| Mar 31, 2023 | 560,000.00 |
| Dec 31, 2022 | 22,000.00 |
| Sep 30, 2022 | 104,000.00 |
| Jun 30, 2022 | 182,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Dec 31, 2021 | 319,000.00 |
| Sep 30, 2021 | 339,000.00 |
| Jun 30, 2021 | 293,000.00 |
| Mar 31, 2021 | 688,000.00 |
| Dec 31, 2020 | 20,000.00 |
| Sep 30, 2020 | 395,000.00 |
| Jun 30, 2020 | 201,000.00 |
| Mar 31, 2020 | 75,000.00 |
| Dec 31, 2019 | -27,000.00 |
| Sep 30, 2019 | 132.32 Mn |
API Access
Tvardi Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();